Viridian Therapeutics VRDN - Options Chain | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Viridian Therapeutics Inc (VRDN)
Viridian Therapeutics Inc (VRDN) Options

Viridian Therapeutics Inc (VRDN)

15.94

0.06

(0.38%)

Closed 10 March 7:00AM

Delayed by 15 minutes

15.90

-0.04

(-0.25%)

After Hours: 9:59AM

Delayed by 15 minutes

VRDN Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	11.50	15.80	0.00	13.65	0.00	0.00 %	0	0	-
5.00	9.00	13.40	0.00	11.20	0.00	0.00 %	0	0	-
7.50	6.60	11.00	0.00	8.80	0.00	0.00 %	0	0	-
10.00	4.10	8.40	0.00	6.25	0.00	0.00 %	0	0	-
12.50	1.75	5.40	0.00	3.575	0.00	0.00 %	0	0	-
15.00	0.25	4.90	1.09	2.575	0.00	0.00 %	0	3	-
17.50	0.10	0.45	0.58	0.275	0.00	0.00 %	0	113	-
20.00	0.01	3.80	0.01	1.905	0.00	0.00 %	0	22	-
22.50	0.34	0.10	0.34	0.22	0.00	0.00 %	0	179	-
25.00	0.20	4.90	0.20	2.55	0.00	0.00 %	0	10	-
30.00	0.00	4.40	0.00	0.00	0.00	0.00 %	0	0	-

Professional-Grade Tools, for Individual Investors.

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	0.00	4.90	0.00	0.00	0.00	0.00 %	0	0	-
5.00	0.00	4.90	0.00	0.00	0.00	0.00 %	0	0	-
7.50	0.00	4.90	0.00	0.00	0.00	0.00 %	0	0	-
10.00	0.00	1.25	0.00	0.00	0.00	0.00 %	0	0	-
12.50	0.00	1.05	0.00	0.00	0.00	0.00 %	0	0	-
15.00	0.10	4.90	0.80	2.50	0.00	0.00 %	0	144	-
17.50	0.20	3.30	2.17	1.75	0.00	0.00 %	0	6	-
20.00	1.85	5.80	0.00	3.825	0.00	0.00 %	0	0	-
22.50	4.30	8.50	0.00	6.40	0.00	0.00 %	0	0	-
25.00	7.00	11.00	0.00	9.00	0.00	0.00 %	0	0	-
30.00	11.90	16.00	0.00	13.95	0.00	0.00 %	0	0	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CAPSCapstone Holding Corp	US$ 3.50 (1,300.00%)	36.33k
ABLVAble View Global Inc	US$ 1.73 (137.18%)	5.13M
SUNESUNation Energy Inc	US$ 0.402999 (127.55%)	476.73M
BTOGBit Origin Ltd	US$ 0.6117 (118.46%)	618.03M
DWTXDogwood Therapeutics Inc	US$ 6.63 (49.66%)	25.77M
ALBTAvalon GloboCare Corporation	US$ 6.96 (-36.15%)	577.55k
SCNXScienture Holdings Inc	US$ 1.55 (-35.68%)	1.59M
ACXPAcurx Pharmaceuticals Inc	US$ 0.4572 (-29.88%)	1.18M
RETOReTo Eco Solutions Inc	US$ 5.42 (-27.73%)	108.27k
OCTOEightco Holdings Inc	US$ 1.08 (-27.03%)	336.99k
BTOGBit Origin Ltd	US$ 0.6117 (118.46%)	622.67M
SUNESUNation Energy Inc	US$ 0.402999 (127.55%)	482.05M
NVDANVIDIA Corporation	US$ 112.69 (1.92%)	341.94M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 10.675 (-0.70%)	143.04M
ICONIcon Energy Corporation	US$ 0.169898 (17.17%)	142.23M

Monksdream

Monksdream 6 months ago

VRDN more upside possible

it_happens

it_happens 6 months ago

Touched 20s today. Maybe it will stay above 20 tomorrow

power11

power11 6 months ago

LOW 20'S BY WEEKEND IMO !!!
GOOD LUCK

it_happens

it_happens 6 months ago

Good news. I don't think that this is merely a one-day runner.

power11

power11 6 months ago

BTIG RESEARCH ADJUST PRICE TARGET TO 56 FROM 46; STRONG BUY !!

it_happens

it_happens 6 months ago

Over 15 and having a good day today

Monksdream

Monksdream 6 months ago

Apprentice

Apprentice 3 years ago

I put into it a lot of $
423 shares!

Apprentice

Apprentice 3 years ago

It just doesn't want to move above $18
Yet, it's not diving much either.
What do you think at this point? Sell temporarily and by later low?
My average is too high @17.76 !

crudeoil24

crudeoil24 3 years ago

Viridian Therapeutics, Inc., formerly Miragen Therapeutics, Inc., is a biotechnology company. The Company is engaged in developing multiple product candidates to treat patients who suffer from thyroid eye disease (TED), a debilitating orphan disease, and has early-stage programs focused on other targets and indications. Its lead candidate, VRDN-001, is a clinical-stage anti-IGF-1R monoclonal antibody (mAb) that is under development for thyroid eye disease (TED). The Company's TED pipeline also includes VRDN-002 and VRDN-003. Its other programs include VRDN-004, which is under development for undisclosed rare orphan disease, and VRDN-005, which is under development for tick-borne disease (TBD). The Company also out licenses its programs.

Viridian Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions